title: Safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1,362 patients.
authors.affiliation: Division of Cardiology, Lehigh Valley Health Network, Allentown, PA, United States. Electronic address: garg.jalaj@yahoo.com.
authors.forename: Jalaj
authors.initials: J
authors.lastname: Garg
authors.affiliation: Department of Medicine, Sinai Hospital of Baltimore, Johns Hopkins University, Baltimore, MD, United States.
authors.forename: Rahul
authors.initials: R
authors.lastname: Chaudhary
authors.affiliation: Department of Medicine, Division of Cardiology, Einstein Healthcare Network, Philadelphia, PA, United States.
authors.forename: Parasuram
authors.initials: P
authors.lastname: Krishnamoorthy
authors.affiliation: Division of Cardiology, Lehigh Valley Health Network, Allentown, PA, United States.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Shah
authors.affiliation: Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, TX, United States.
authors.forename: Andrea
authors.initials: A
authors.lastname: Natale
authors.affiliation: Division of Cardiology, Lehigh Valley Health Network, Allentown, PA, United States.
authors.forename: Babak
authors.initials: B
authors.lastname: Bozorgnia
mesh_terms: D001281:Atrial Fibrillation / Q000601:surgery*; D017115:Catheter Ablation; D006801:Humans; D015201:Meta-Analysis as Topic; D011300:Preoperative Care / Q000379:methods*; D020521:Stroke / Q000517:prevention & control*; D016896:Treatment Outcome
keywords: Anticoagulation; Atrial fibrillation ablation; Rivaroxaban; Thromboembolism